Genus plc (GNS)
LSE
Closed
Aug 24, 2026
Day's Range
2,250.0052 wk Range
1,943.00Overview - GNS - Genus plc
Key Statistics
Valuation
Enterprise Value
1.72B
P/E (Trailing)
‪32.14‬
P/E (Forward)
‪21.86‬
Price / Sales (TTM)
‪2.25‬
Price / Book
‪299.23‬
EV / EBITDA
‪17.95‬
Profitability
Profit Margin
‪7.06%‬
Operating Margin
‪14.51%‬
Return on Assets
‪5.41%‬
Return on Equity
‪9.35%‬
Ownership
Shares Outstanding
66.41M
Float
65.11M
Held by Insiders
‪0.60%‬
Held by Institutions
‪78.88%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪2,194.24‬
200-Day Avg
‪2,501.05‬
Dividends
Payout Ratio
‪45.06%‬
Frequency
Semi-Annual
Analyst Consensus
12 analysts
Average price target
‪£ 3,079.00‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - GNS - Genus plc
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
Profile Summary - GNS - Genus plc
About
Genus plc is a public limited company specializing in animal genetics, pioneering genetic improvement to help farmers produce high-quality milk and meat more efficiently and sustainably. Through its two main business units, ABS for dairy and beef cattle and PIC for pigs, it develops genetically superior breeding…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
